News

November 19, 2019

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

ProMab has recently had our work published in JoVE on the real-time cytotoxicity assay (RTCA) that we use […]
October 31, 2019

NantKwest Signs Worldwide License Agreement with ProMab

Initially Launching a Novel, High-Affinity BCMA CAR Targeting NK Cell Development Candidate For Multiple Myeloma, With An Option […]
August 21, 2019

CAR-TCR Summit 2019

CAR-TCR Summit 2019 Come visit the ProMab team and learn about our new products & services Booth #50 […]
May 9, 2019

ASCO Annual Meeting 2019

ASCO Annual Meeting 2019 Come visit the ProMab team and learn about our new products & services Booth […]
April 10, 2018

Expanding our CRO capabilities to now include TCR and BCR profiling

We are now offering Assay for full length reads of V{D)J regions: Mouse TCR Bulk Cell Profiling – […]
April 10, 2018

Helix BioPharma Corp Signs Collaboration Agreement With Promab Biotechnologies To Co-Develop CAR-T For Hematological Malignancies

(Richmond Hill, Ontario) – Helix BioPharma Corp. (TSX, FSE: “HBP”) (“Helix” or the “Company”), a immuno-oncology company developing […]
April 10, 2018

AACR Annual Meeting 2018

Come visit the ProMab team and learn about new products & services Booth #1753 April 14 – 18, […]
December 3, 2013

Ascites Production Service

ProMab is proud to announce the launch of our ascites production service as an alternative to our other […]
July 30, 2013

Featured Publications: The Intracellular Citrus Huanglongbing Bacterium, ‘Candidatus Liberibacter asiaticus’ Encodes Two Novel Autotransporters

Every month, ProMab features one of the latest publications in research that reference our products or custom antibody […]
April 18, 2013

Custom Antibody Services

ProMab is proud to announce promotions in a number of our custom antibody services as listed below.